Category: Pharma Industry

Merck Offering Refunds to 340B Covered Entities

September 12, 2023 Tom Mirga, Editor at Large Views

Merck is the first drug manufacturer to announce it is issuing refunds to 340B providers in 2024.

Drug manufacturer Merck recently announced that it owes refunds to 340B covered entities for purchases of 17 products during the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sources Cited in Drugmakers’ Brief Question Accuracy in High-Profile 340B Patient Definition Case

September 8, 2023 Tom Mirga, Editor at Large Views

Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.

Inaccurate points were ascribed to 340B advisers and service providers in a recent legal filing by four drugmakers as part [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Janssen Issuing Refunds for 340B Overcharges

September 8, 2023 Tom Mirga, Editor at Large Views

Janssen Biotech is paying refunds for overcharges on certain 340B drugs purchased in the third quarter of 2020.

Drug manufacturer Janssen Biotech recently determined that it owes or may owe refunds to some 340B covered entities. The refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

PhRMA to Federal Appeals Court: Arkansas Enforcing 340B Contract Pharmacy Law; Seventh Drugmaker Sues Over IRA

September 6, 2023 William Newton, Associate Editor/Senior Writer Views

PhRMA filed a citation to notify the U.S. Eighth Circuit Court of Appeals in St. Louis that Arkansas is enforcing its 340B contract pharmacy law.

The drug industry group challenging the legality of Arkansas’ 340B contract pharmacy law, notified a federal appeals court that the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Tolmar Providing Refunds for Five Years of 340B Overcharges

September 6, 2023 Tom Mirga, Editor at Large Views

Drugmaker Tolmar said it will refund 340B covered entities for overcharges on certain generic dermatologic products.

Drug manufacturer Tolmar recently said it plans refunds to 340B covered entities for overcharges on seven generic dermatologic products purchased [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UCB Tightens 340B Contract Pharmacy Restrictions for Hospitals

September 5, 2023 William Newton, Associate Editor/Senior Writer Views

UCB announced it will tighten its existing 340B contract restrictions on hospitals beginning Oct. 2.

Belgium drug maker UCB will add restrictions on 340B contract pharmacy use for hospitals starting Oct. 2, according to a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

EMD Serono Extends Hospital 340B Contract Pharmacy Conditions to All Products

September 1, 2023 William Newton, Associate Editor/Senior Writer Views

Beginning Oct. 1, EMD Serono will extend its contract pharmacy restrictions to all 340B covered entities.

Drug manufacturer EMD Serono (EMDS) today announced 340B contract pharmacy restrictions for hospitals will expand Oct. 1 to all of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Initiates First-in-the-Nation Enforcement of 340B Contract Pharmacy Law

August 31, 2023 William Newton, Associate Editor/Senior Writer Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

The Arkansas Insurance Department (AID) has formally notified at least four drugmakers that they are in potential violation of a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Boehringer Ingelheim Sues to Block Medicare Price Negotiations

August 31, 2023 William Newton, Associate Editor/Senior Writer Views

Boehringer Ingelheim sued the federal government to block Medicare price negotiations shortly before its diabetes drug was picked for negotiations.

Drug maker Boehringer Ingelheim (BI) sued the federal government to block Medicare price negotiations shortly before the Department of Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Centers Fear Losing 340B Pricing From Sanofi at Multiple Contract Pharmacies

August 29, 2023 Tom Mirga, Editor at Large Views

Changes to Sanofi's 340B drug pricing conditions may eliminate 340B discounts for health centers using multiple contract pharmacies within a chain.

Recent apparent changes to 340B drug pricing conditions by drug manufacturer Sanofi may eliminate 340B discounts for health centers using [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Pharma Industry

Merck Offering Refunds to 340B Covered Entities

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Sources Cited in Drugmakers’ Brief Question Accuracy in High-Profile 340B Patient Definition Case

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Janssen Issuing Refunds for 340B Overcharges

Please Login or Become a Paid Subscriber to View this Content

If you are already a

PhRMA to Federal Appeals Court: Arkansas Enforcing 340B Contract Pharmacy Law; Seventh Drugmaker Sues Over IRA

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Tolmar Providing Refunds for Five Years of 340B Overcharges

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

UCB Tightens 340B Contract Pharmacy Restrictions for Hospitals

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

EMD Serono Extends Hospital 340B Contract Pharmacy Conditions to All Products

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Arkansas Initiates First-in-the-Nation Enforcement of 340B Contract Pharmacy Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Boehringer Ingelheim Sues to Block Medicare Price Negotiations

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Health Centers Fear Losing 340B Pricing From Sanofi at Multiple Contract Pharmacies

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live